New indications for botulinum toxin in rheumatology

Joint Bone Spine

Volumn 73, Issue 6, 2006, Pages 667-671

  Monnier, Guy ^a   Tatu, Laurent ^a   Michel, Fabrice ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Botulinum toxin; Chronic myofascial pain; Rheumatology

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ASTHENIA; AUTONOMIC DYSFUNCTION; BLEPHAROSPASM; CERVICAL SPINE; CHRONIC PAIN; COLD SENSITIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DYSTONIA; ELECTROMYOGRAPHY; EPICONDYLITIS; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEMATOMA; HEMIFACIAL SPASM; HUMAN; HYPERHIDROSIS; INJECTION SITE PAIN; INVOLUNTARY MOVEMENT; LOW BACK PAIN; LUMBAR SPINE; MUSCULOSKELETAL PAIN; MYOFASCIAL PAIN; PIRIFORMIS MUSCLE SYNDROME; RHEUMATIC DISEASE; SHORT SURVEY; SIDE EFFECT; SPASTICITY; STIFF PERSON SYNDROME; SYSTEMATIC REVIEW; TENNIS ELBOW; THORACIC SPINE; THORAX OUTLET SYNDROME; VERTIGO; ARTHRALGIA; CHRONIC DISEASE; REVIEW;

ARTHRALGIA; BOTULINUM TOXINS; CHRONIC DISEASE; HUMANS; MYOFASCIAL PAIN SYNDROMES; RHEUMATIC DISEASES;

EID: 33845473650     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.03.005     Document Type: Short Survey

References (60)

1. Poulain B., and Humeau Y. Le mode d'action des neurotoxines botuliques : aspects pathologiques, cellulaires et moléculaires. Ann. Readapt. Med. Phys. 46 (2003) 286-295
2. Gury C. Aspects pharmacologiques et médicoéconomiques. In: Ranoux D., and Gury C. (Eds). Manuel d'utilisation pratique de la toxine botulique (2002), Solal, Marseille 13-32
3. Graham H.K., Aoki K.R., Autti-Rämö I., Boyd R.N., Delgado M.R., Gaebler-Spina D.J., et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 11 (2000) 67-79
4. Gury C., Duneau M., and Ranoux D. Aspects réglementaires. In: Ranoux D., and Gury C. (Eds). Manuel d'utilisation pratique de la toxine botulique (2002), Solal, Marseille 263-270
5. Jankovic J., and Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 40 (1990) 277-280
6. Thant Z.S., and Tan E.K. Emerging therapeutic applications of botulinum toxin. Med. Sci. Monit. 9 (2003) RA40-RA48
7. Wissel J., Muller J., Dressnandt J., Heinen F., Naumann M., and Topka H. Management of spasticity associated pain with botulinum toxin A. J. Pain Symptom Manage. 20 (2000) 44-49
8. Simon O., Raibaut P., Faucher M., Sheik-Ismael S., and Amarenco G. Toxine botulique et céphalées. Ann. Readapt. Med. Phys. 46 (2003) 312-318
9. Rosales R.L., Arimura K., Takenaga S., and Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19 (1996) 488-496
10. Filippi G.M., Errico P., Santarelli R., Bagolini B., and Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 113 (1993) 400-404
11. Wiegand H., Erdmann G., and Wellhoner H.H. 125 I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebers Arch. Pharmacol. 292 (1976) 161-165
12. Wiegand H., and Wellhoner H.H. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch. Pharmacol. 298 (1977) 235-238
13. Aoki K.R. Pharmacology and immunology of botulinum toxin serotypes. J. Neurol. 248 Suppl 1 (2001) 3-10
14. Göbel H., Lindner V., Krack P., Heinze A., Gaartz N., and Deuschl G. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 19 (1999) 455
15. Borodic G.E., Acquadro M., and Johnson E.A. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin. Investig. Drugs 10 (2001) 1531-1544
16. Welch M.J., Purkiss J.R., and Foster K.A. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38 (2000) 245-258
17. Cui M., and Aoki R. Botulinum toxin A inhibits the inflammatory pain in the rat formalin model. Cephalalgia 20 (2000) 20-41
18. Humm A.M., Pabst C., Lauterburg T., and Burgunder J.M. Enkephalin and aFGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin. Exp. Neurol. 161 (2000) 361-372
19. Lorentz I.T., Subramaniam S.S., and Yiannikas C. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double blind study on twenty-three patients. Mov. Disord. 6 (1991) 145-150
20. Ceballos-Baumann A.O. Evidence-based medicine in botulinum toxin therapy for cervical dystonia. J. Neurol. 248 Suppl 1 (2001) 14-20
21. Paulson G.W., and Gill W. Botulinum toxin is unsatisfactory therapy for fibromyalgia. Mov. Disord. 11 (1996) 459
22. Sheean G. Botulinum toxin for the treatment of musculoskeletal pain and spasm. Curr. Pain Headache Rep. 6 (2002) 460-469
23. Lang A.M. Botulinum toxin type A therapy in chronic pain disorders. Arch. Phys. Med. Rehabil. 84 Suppl 1 (2003) 69-73
24. Borodic G.E., and Acquadro M.A. The use of botulinum toxin for the treatment of chronic facial pain. J. Pain 3 (2002) 21-27
25. Tsui J.K., Eisen A., Stoessl A.J., Calne S., and Calne D.B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2 (1986) 245-247
26. Acquadro M.A., and Borodic G.E. Treatment of myofascial pain with botulinum A toxin. Anesthesiology 80 (1994) 705-706
27. Cheshire W.P., Abashian S.W., and Mann J.D. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59 (1994) 65-69
28. Alo K.M., Yland M.J., and Kramer D.L. Botulinum toxin in the treatment of myofascial pain. Pain Clin. 10 (1997) 107-116
29. De Seze M.P., DE Seze M., Dehail P., Joseph P.A., Lavignolle B., and Barat M. Toxine botulique A et douleurs musculosquelettiques. Ann. Readapt. Med. Phys. 46 (2003) 329-332
30. Wheeler A.H., Goolkasian P., and Gretz S.S. Botulinum toxin A for the treatment of chronic neck pain. Pain 94 (2001) 255-260
31. Freund B.J., and Schwartz M. Treatment of whiplash associated neck pain with botulinum toxin-A: report of 8 cases. J. Rheumatol. 26 (1999) 756-758
32. Freund B.J., and Schwartz M. Treatment of whiplash associated neck pain (corrected) with botulinum toxin-A: a pilot study. J. Rhumatol. 27 (2000) 481-484
33. Wheeler A.H., Goolkasian P., and Gretz S.S. A randomized double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 23 (1998) 1662-1666
34. Wheeler A.H., and Goolkasian P. Open label assessment of botulinum toxin A for pain treatment in a private outpatient setting. J. Musculoskeletal Pain 9 (2001) 67-82
35. ®), administered using a novel injection technique, for the treatment of myofascial pain. Am. J. Pain Manage 10 (2000) 108-112
36. Royal M.A., Gunyea I., Bhakta B., Movva V., Ward S., and Jenson M. Botulinum toxin type A in the treatment of refractory myofascial pain. Neurology 56 Suppl 3 (2001) 350 [abstract]
37. Foster L., Clapp L., Erickson M., and Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 56 (2001) 1290-1293
38. Difazio M., and Jabbari B. A focused review of the use of botulinum toxins for low back pain. Clin. J. Pain 18 6 Suppl (2002) 155-162
39. Jost W.H., Reilich P., and Pongratz D. Botulinum toxin in low back pain. In: Jost W.H. (Ed). Botulinum toxin in painful diseases. Pain headache vol. 14 (2003), Karger, Basel 159-169
40. Fanucci E., Masala S., Sodani G., Varrucciu V., Romagnoli A., and Squillaci E. CT guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process. Eur. Radiol. 11 (2001) 2543-2548
41. Fishman L.M., Anderson C., and Rosner B. Botox and physical therapy in the treatment of piriformis syndrome. Am. J. Phys. Med. Rehabil. 81 (2002) 936-942
42. Childers M.K., Wilson D.J., Gnatz S.M., Conway R.R., and Sherman A.K. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am. J. Phys. Med. Rehabil. 81 (2002) 751-759
43. Lang A.M. Botulinum toxin type B in piriformis syndrome. Am. J. Phys. Med. Rehabil. 83 (2004) 198-202
44. Fishman L.M., Konnoth C., and Rozner B. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose finding study. Am. J. Phys. Med. Rehabil. 83 (2004) 42-50
45. Placzek R., Lindner M.S., and Deuretzbacher G. Therapy for chronic radial epicondylitis with botulinum toxin A. Z. Orthop. Ihre Grenzgeb. 142 (2004) 701-705 [switch these two references]
46. Hayton M.J., Santini A.J., Hugues P.J., Frostick S.P., Trail J.A., and Stanley J.K. Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled, pilot study. J. Bone Joint Surg. Am. 87 (2005) 503-507
47. Keizer S.B., Rutten H.P., Pilot P., Morre H.H., Vos J.J., and Verburg A.D. Botulinum toxin injection versus surgical treatment for tennis elbow: a randomized pilot study. Clin. Orthop. Relat. Res. 401 (2002) 125-131
48. Davis D., and Jabbari B. Significant improvement of stiff-person syndrome after para-spinal injection of botulinum toxin A. Mov. Disord. 8 (1993) 371-373
49. Liguori R., Cordivari C., Lugaresi E., and Montagna P. Botulinum toxin A improves muscle spasms and rigidity in stiff-person syndrome. Mov. Disord. 12 (1997) 1060-1063
50. Simons D.G., Travell J.G., and Simons L.S. Travell and Simons'myofascial pain and dysfunction: the trigger point manual, vol. I: Upper half of body, ed. 2 (1999), Williams and Wilkins, Baltimore
51. Wolfe F., Simons D.G., and Fricton J. The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J. Rheumatol. 19 (1992) 944-951
52. Comella C.L., Buchman A.S., Tanner C.M., Brown-Toms N.C., and Goetz G. Botulinum toxin injections for spasmodic torticollis: increased magnitude of benefits with electromyographic assistance. Neurology 42 (1992) 878-882
53. Brown J.A., Braun M.A., and Namey T.C. Piriformis syndrome in a 10-year-old boy as a complication of operation with the patient in the sitting position. Neurosurgery 23 (1988) 117-119
54. Goussard J.C. Le syndrome du pyramidal. Aspects cliniques et traitement. Rev. Med. Orthoped. 19 (1990) 27-31
55. Pace J.B., and Nagle D. Piriform syndrome. West. J. Med. 47 (1976) 1144-1146
56. Freiberg A.H. The fascial elements in associated low-back and sciatic pain. J. Bone Joint Surg. 16 (1934) 126-136
57. Beatty R.A. The piriformis muscle syndrome: a simple diagnostic manoeuver. Neurosurgery 34 (1994) 512-514
58. Fishman L.M., and Zybert P.A. Electrophysiologic evidence of piriformis syndrome. Arch. Phys. Med. Rehabil. 73 (1992) 359-364
59. Benzon H.T., Katz J.A., and Benzon H.A. Piriformis syndrome: anatomic considerations, a new injection technique, and a review of the literature. Anesthesiology 98 (2003) 1442-1448
60. Boisaubert B., Brousse C., Zaoui A., and Montigny J.P. Les traitements non chirurgicaux de la tendinopathie des épicondyliens. Ann. Readapt. Med. Phys. 47 (2004) 346-355